Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth
Robbert G. van der Most, Andrew J. Currie, Amanda L. Cleaver et al. · 2009
Read Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth by Robbert G. van der Most, Andrew J. Currie, Amanda L. Cleaver et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006982.txt.
Description
Robbert van der Most, Andrew Currie, Amanda Cleaver, and colleagues combined chemotherapy with immune attack in PLOS ONE in 2009. A cancer drug can both drain immune cells and stir them up. Earlier work showed chemotherapy can team well with immunotherapy. The question was how to turn that pairing into tumor control.
Using cyclophosphamide, the team made tumor cells more open to immune killing. The attack depended on a death signal called TRAIL and on CD8 T cells. Tumor growth was then suppressed. The result supports schedules that use chemo first to soften tumors for the immune system.
Catalog record
| CREATOR | Robbert G. van der Most, Andrew J. Currie, Amanda L. Cleaver et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006982